Dabigatran etexilate

Strength: 75 mg, 110 mg, 150 mg

Dosage Form: Capsule

Description:

Dabigatran etexilate is an oral direct thrombin inhibitor that prevents clot formation by blocking thrombin activity. It is indicated for stroke prevention in atrial fibrillation, treatment and prevention of deep vein thrombosis and pulmonary embolism.

Key Features:

• No need for routine blood monitoring
• Predictable anticoagulant effects
• Rapid onset and offset of action

Precautions:

Not recommended in patients with mechanical heart valves. Use cautiously in renal impairment. Increased bleeding risk—monitor closely.